Reduced-dose Antiarrhythmic Drugs: Valuable or Valueless?
作者信息
Reiffel James A
机构信息
Department of Medicine, Division of Cardiology, Electrophysiology Section, Columbia University, New York, NY, USA.
出版信息
J Innov Card Rhythm Manag. 2020 Apr 15;11(4):4063-4067. doi: 10.19102/icrm.2020.110404. eCollection 2020 Apr.
Abstract
摘要
相似文献
1
Reduced-dose Antiarrhythmic Drugs: Valuable or Valueless?低剂量抗心律失常药物：有价值还是无价值？
J Innov Card Rhythm Manag. 2020 Apr 15;11(4):4063-4067. doi: 10.19102/icrm.2020.110404. eCollection 2020 Apr.
2
[Antiarrhythmic therapy in patients with heart failure].心力衰竭患者的抗心律失常治疗
Ther Umsch. 2000 May;57(5):324-32. doi: 10.1024/0040-5930.57.5.324.
3
The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction.胺碘酮和去乙基胺碘酮单独及联合应用对急性心肌梗死犬的抗心律失常疗效。
Circulation. 1988 Jan;77(1):200-8. doi: 10.1161/01.cir.77.1.200.
4
Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study.序贯抗心律失常治疗：胺碘酮在预防房颤复发中的作用——来自波兰HOT CAFE研究的经验教训
Cardiology. 2005;104(1):35-44. doi: 10.1159/000086053. Epub 2005 May 4.
5
Effect of amiodarone and sotalol on the defibrillation threshold in comparison to patients without antiarrhythmic drug treatment.与未接受抗心律失常药物治疗的患者相比，胺碘酮和索他洛尔对除颤阈值的影响。
Int J Cardiol. 1999 Jun 1;69(3):271-9. doi: 10.1016/s0167-5273(99)00055-8.
6
Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy.危及生命的持续性室性快速心律失常患者的管理——指导性抗心律失常药物治疗的作用
Prog Cardiovasc Dis. 1996 May-Jun;38(6):419-28. doi: 10.1016/s0033-0620(96)80006-5.
7
[Combination anti-arrhythmic drug therapy].联合抗心律失常药物治疗
Z Kardiol. 1992;81 Suppl 4:157-61.
8
Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.伴有植入式心律转复除颤器（ICD）电击的室性心动过速：何时药物治疗以及何时消融
Curr Cardiol Rep. 2017 Sep 13;19(11):105. doi: 10.1007/s11886-017-0924-0.
9
[Antiarrhythmic drugs in atrial fibrillation].[心房颤动中的抗心律失常药物]
Rev Prat. 2002 Jun 15;52(12):1317-23.
10
Basic and clinical pharmacology of amiodarone: relationship of antiarrhythmic effects, dose and drug concentrations to intracellular inclusion bodies.胺碘酮的基础与临床药理学：抗心律失常作用、剂量及药物浓度与细胞内包涵体的关系
J Clin Pharmacol. 1989 May;29(5):405-12. doi: 10.1002/j.1552-4604.1989.tb03352.x.
引用本文的文献
1
Practical Compendium of Antiarrhythmic Drugs: A Clinical Consensus Statement of the European Heart Rhythm Association of the ESC.抗心律失常药物实用手册：欧洲心脏病学会（ESC）欧洲心律协会临床共识声明
Europace. 2025 Mar 30. doi: 10.1093/europace/euaf076.
2
Cardiotoxicity evaluation of two-drug fixed-dose combination therapy under CiPA: a computational study.基于CiPA的两药固定剂量联合疗法的心脏毒性评估：一项计算研究
Transl Clin Pharmacol. 2024 Dec;32(4):198-215. doi: 10.12793/tcp.2024.32.e20. Epub 2024 Dec 27.
本文引用的文献
1
Low-dose Amiodarone Is Safe: A Systematic Review and Meta-analysis.低剂量胺碘酮是安全的：一项系统评价和荟萃分析。
J Innov Card Rhythm Manag. 2020 Apr 15;11(4):4054-4061. doi: 10.19102/icrm.2020.110403. eCollection 2020 Apr.
2
Efficacy and Safety of Low-Dose Amiodarone Therapy for Tachyarrhythmia in Congenital Heart Disease.小剂量胺碘酮治疗先天性心脏病快速性心律失常的疗效与安全性
Pediatr Cardiol. 2018 Jun;39(5):1016-1022. doi: 10.1007/s00246-018-1853-4. Epub 2018 Mar 9.
3
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.2016年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动管理指南。
Eur Heart J. 2016 Oct 7;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210. Epub 2016 Aug 27.
4
The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism.HARMONY试验：联合使用雷诺嗪和决奈达隆治疗阵发性心房颤动：机制与治疗协同作用
Circ Arrhythm Electrophysiol. 2015 Oct;8(5):1048-56. doi: 10.1161/CIRCEP.115.002856. Epub 2015 Jul 30.
5
Incidence, Clinical Course, and Risk Factors of Amiodarone-Induced Thyroid Dysfunction in Japanese Adults With Congenital Heart Disease.日本先天性心脏病成年患者中胺碘酮所致甲状腺功能障碍的发病率、临床病程及危险因素
Circ J. 2015;79(8):1828-34. doi: 10.1253/circj.CJ-15-0042. Epub 2015 May 27.
6
7
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南：执行摘要：美国心脏病学会/美国心脏协会实践指南工作组和心律学会的报告
Circulation. 2014 Dec 2;130(23):2071-104. doi: 10.1161/CIR.0000000000000040. Epub 2014 Mar 28.
8
Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations.抗心律失常药物联合治疗增强对心房颤动的窦性节律维持。
J Cardiovasc Pharmacol Ther. 2010 Dec;15(4 Suppl):31S-5S. doi: 10.1177/1074248410377617.
9
Use of bepridil in combination with Ic antiarrhythmic agent in converting persistent atrial fibrillation to sinus rhythm.使用苄普地尔与Ic类抗心律失常药物联合将持续性心房颤动转为窦性心律。
Circ J. 2008 May;72(5):709-15. doi: 10.1253/circj.72.709.
Zotero 插件